Cell Cycle Deregulation and TP53 and RAS Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas

作者: Jaime Miguel Pita , Inês Filipa Figueiredo , Margarida Maria Moura , Valeriano Leite , Branca Maria Cavaco

DOI: 10.1210/JC.2013-1512

关键词:

摘要: Background: Anaplastic thyroid carcinomas (ATCs) are among the most lethal malignancies, for which there is no effective treatment. Objective: In present study, we aimed to elucidate molecular alterations contributing ATC development and identify novel therapeutic targets. Design: We profiled global gene expression of five ATCs validated differentially expressed genes by quantitative RT-PCR in an independent set tumors. a series 26 ATCs, searched pathogenic involved deregulated cellular processes, including hot spot regions RAS, BRAF, TP53, CTNNB1 (β-catenin), PIK3CA genes, and, first time, comprehensive analysis components cell cycle [cyclin-dependent kinase (CDK) inhibitors (CDKI): CDKN1A (p21CIP1); CDKN1B (p27KIP1); CDKN2A (p14ARF, p16INK4A); CDKN2B (p15INK4B); CDKN2C (p18INK4C)], adhesion (AXIN1), proliferation (PTEN). Mutational was also performed 22 poorly differentiate...

参考文章(89)
E.N. Imyanitov, M.Yu. Grigoriev, V.M. Gorodinskaya, E.Sh. Kuligina, K.M. Pozharisski, A.V. Togo, K.P. Hanson, Partial restoration of degraded DNA from archival paraffin-embedded tissues. BioTechniques. ,vol. 31, pp. 1000- 1002 ,(2001) , 10.2144/01315BM04
R Soong, B Powell, H Elsaleh, G Gnanasampanthan, D.R Smith, H.S Goh, D Joseph, B Iacopetta, Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma: influence of tumour site, stage, adjuvant chemotherapy and type of mutation European Journal of Cancer. ,vol. 36, pp. 2053- 2060 ,(2000) , 10.1016/S0959-8049(00)00285-9
Curtis Mettlin, Jack A. Taylor, William J. Vogler, Tom Mason, Yu Li, Mei He, Edison Liu, Susan Maygarden, p53 Mutations in Bladder Tumors from Arylamine-exposed Workers Cancer Research. ,vol. 56, pp. 294- 298 ,(1996)
Martin Deichmann, Marianne Thome, Axel Benner, Martin Kirschner, Judith Hassanzadeh, Hjalmar Kurzen, Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases BMC Cancer. ,vol. 5, pp. 58- 58 ,(2005) , 10.1186/1471-2407-5-58
Ajit Nambiar, Sunil Pv, Vijaylakshmi Susheelan, Moni Abraham Kuriakose, The concepts in poorly differentiated carcinoma of the thyroid: A review article Journal of Surgical Oncology. ,vol. 103, pp. 818- 821 ,(2011) , 10.1002/JSO.21803
Ginesa Garcia-Rostan, Robert L. Camp, Agustin Herrero, Maria Luisa Carcangiu, David L. Rimm, Giovanni Tallini, β-Catenin Dysregulation in Thyroid Neoplasms The American Journal of Pathology. ,vol. 158, pp. 987- 996 ,(2001) , 10.1016/S0002-9440(10)64045-X
Paul Komminoth, Jan Zedenius, Tony Frisk, Charis Eng, Charis Eng, Debbie J. Marsh, Ramon Parsons, Michel Longy, Zimu Zheng, Patricia L M Dahia, Goran Wallin, Catharina Larsson, Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors Cancer Research. ,vol. 57, pp. 4710- 4713 ,(1997)
Y Wang, V N Ngo, M Marani, Y Yang, G Wright, L M Staudt, J Downward, Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells Oncogene. ,vol. 29, pp. 4658- 4670 ,(2010) , 10.1038/ONC.2010.218
Remo Calabrese, Emidio Capriotti, Piero Fariselli, Pier Luigi Martelli, Rita Casadio, Functional annotations improve the predictive score of human disease-related mutations in proteins Human Mutation. ,vol. 30, pp. 1237- 1244 ,(2009) , 10.1002/HUMU.21047
Takeshi Kurihara, Satoshi Ikeda, Yasuyo Ishizaki, Masahiko Fujimori, Noriaki Tokumoto, Yuzoh Hirata, Shinji Ozaki, Masazumi Okajima, Keizo Sugino, Toshimasa Asahara, Immunohistochemical and sequencing analyses of the Wnt signaling components in Japanese anaplastic thyroid cancers. Thyroid. ,vol. 14, pp. 1020- 1029 ,(2004) , 10.1089/THY.2004.14.1020